Our Mission is providing the world medical community with the very first radiation free and office-based solution for the Early Diagnosis of Osteoporosis.
We want to be in the forefront of innovation in the healthcare industry, introducing new advanced products to contribute to human welfare by application of biomedical engineering in the research, design, production, and sale of new non-invasive solutions essential to give people a better life.
Echolight is a high-tech biomedical company for the development of innovative medical devices focused on the diagnosis of osteoporosis.
The company was incorporated in 2010 by the founding team as a spin-off of the National Council of Research, expanding over the years its company structure.
Headquartes is based inside the University and Research Campus Ecotekne in Lecce – Italy – and it is led by a team with over 250 years of cumulative experience working in the medical field.
Echolight will be the new worldwide benchmark for the medical community focusing its growth in the development of advanced and easy to use technologies for primary care procedures.
Bone. Health. Life.
The Italian Government strongly supports innovative tech Startups in order to increase growth. So, growth is our Mission. Invitalia Ventures is born to take this challenge and make it come true. Owned by National Agency for Development (Invitalia S.p.A.), Invitalia Ventures manages Italia Venture I Fund to actively coinvest with national and international VC to enforce Venture Industry and Italian innovative startups.
Panakes Partners is a Venture Capital investor that finances medical companies with extremely promising products and great ambition. Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.
The company is based on the concept of creating a financial vehicle to invest in the lifesciences sector with particular emphasis on new medical and diagnostic technologies. LSC therefore offers itself as a strategic and financial partner to the universe of italian lifesciences companies and as a potential partner to international venture capital funds interested in investing through a highly qualified structure.
Research & Dreams.
Echolight secured all the standard certifications: UNI CEI EN ISO 13485: 2012, ISO 13485: 2003, UNI EN ISO 9001: 2008 Quality Management System and the CE mark for Echos, EchoStation and EchoStudio by KIWA CERMET.
In collaboration with the National Council of Research, Echolight has carried out international multi-center studies for the clinical validation of the proprietary technology in the most important reference centers for the diagnosis of osteoporosis under the lead of its scientific advisory board.